{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:07:27Z","timestamp":1772017647300,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Polycystic ovarian syndrome is the most common endocrinopathy in reproductive-aged women and has a vast array of clinical manifestations. Common clinical presentations of the disorder include anovulatory infertility, menstrual disorders, cutaneous symptoms secondary to androgen excess, metabolic abnormalities and mental health issues. If the condition is left unaddressed or inadequately treated, long-term sequelae such as endometrial hyperplasia, diabetes mellitus and dyslipidemia may ensue, therefore it is imperative for clinicians to address each component of the syndrome. When initial lifestyle changes and dietary modifications do not suffice or fail, pharmacologic therapy should be considered, and when deemed appropriate treatment should be initiated. This review describes the pharmacologic options available to combat the various sequelae commonly seen in women with polycystic ovarian syndrome.<\/jats:p>","DOI":"10.1097\/grf.0000000000000597","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T14:30:44Z","timestamp":1608561044000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacologic Treatments for PCOS Patients"],"prefix":"10.1097","volume":"64","author":[{"given":"SAMANTHA","family":"KODAMA","sequence":"first","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SAIOA","family":"TORREALDAY","sequence":"additional","affiliation":[{"name":"Walter Reed National Military Medical Center, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","year":"2008","journal-title":"Fertil Steril"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1210\/jc.2013-1328","article-title":"Clinical review: the use of aromatase inhibitors for ovulation induction and superovulation","volume":"98","author":"Pavone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"R5-20250512","first-page":"Cd010287","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","volume":"5","author":"Franik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.fertnstert.2004.04.070","article-title":"A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation","volume":"82","author":"Al-Fozan","year":"2004","journal-title":"Fertil Steril"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"571.e571","DOI":"10.1016\/j.fertnstert.2018.11.030","article-title":"A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome","volume":"111","author":"Mejia","year":"2019","journal-title":"Fertil Steril"},{"key":"R9-20250512","first-page":"4","article-title":"Polycystic ovary syndrome","volume":"XV","author":"Hoeger","year":"2016","journal-title":"Clin Updates Women\u2019s Health Care"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.fertnstert.2013.05.033","article-title":"Use of clomiphene citrate in infertile women: a committee opinion","volume":"100","year":"2013","journal-title":"Fertil Steril"},{"issue":"suppl 1","key":"R12-20250512","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.fertnstert.2006.03.018","article-title":"Ovulation induction in women with polycystic ovary syndrome","volume":"86","author":"Palomba","year":"2006","journal-title":"Fertil Steril"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0015-0282(16)46033-4","article-title":"A decade\u2019s experience with an individualized clomiphene treatment regimen including its effect on the postcoital test","volume":"37","author":"Gysler","year":"1982","journal-title":"Fert Steril"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(01)02929-6","article-title":"A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"77","author":"Imani","year":"2002","journal-title":"Fertil Steril"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/humrep\/dei128","article-title":"Ovulation induction: a mini review","volume":"20","author":"Messinis","year":"2005","journal-title":"Hum Reprod"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N Engl J Med"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1995.01100040102034","article-title":"Visual disturbance secondary to clomiphene citrate","volume":"113","author":"Purvin","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ajog.2004.05.030","article-title":"Does metformin induce ovulation in normoandrogenic anovulatory women?","volume":"191","author":"Carmina","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2005.05.010","article-title":"Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?","volume":"123","author":"\u00d6nalan","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R25-20250512","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/deg336","article-title":"A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome","volume":"18","author":"Christin-Maitre","year":"2003","journal-title":"Hum Reprod"},{"key":"R26-20250512","first-page":"3821","article-title":"Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women","volume":"81","author":"White","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2014.11.012","article-title":"Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study","volume":"136","author":"Gottschau","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2013.10.028","article-title":"Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?","volume":"132","author":"Shafiee","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"103","author":"Martin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-20250512","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijwd.2017.02.018","article-title":"A review of hormone-based therapies to treat adult acne vulgaris in women","volume":"3","author":"Trivedi","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00403-012-1265-x","article-title":"The role of androgen and androgen receptor in skin-related disorders","volume":"304","author":"Lai","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0015-0282(16)59346-7","article-title":"The endocrine effects of spironolactone used as an antiandrogen","volume":"48","author":"Young","year":"1987","journal-title":"Fertil Steril"},{"key":"R36-20250512","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0015-0282(16)48373-1","article-title":"The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women","volume":"43","author":"Lobo","year":"1985","journal-title":"Fertil Steril"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.bi.63.070194.000325","article-title":"Steroid 5 alpha-reductase: two genes\/two enzymes","volume":"63","author":"Russell","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.fertnstert.2004.02.118","article-title":"Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women","volume":"82","author":"Tartagni","year":"2004","journal-title":"Fertil Steril"},{"key":"R39-20250512","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-118-11-199306010-00006","article-title":"Fatal and nonfatal hepatotoxicity associated with flutamide","volume":"118","author":"Wysowski","year":"1993","journal-title":"Ann Intern Med"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-4632.2006.03079.x","article-title":"Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair","volume":"46","author":"Wolf","year":"2007","journal-title":"Int J Dermatol"},{"key":"R41-20250512","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"R42-20250512","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R43-20250512","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"R44-20250512","doi-asserted-by":"crossref","first-page":"149.e142","DOI":"10.1016\/j.amjmed.2007.09.016","article-title":"Meta-analysis: metformin treatment in persons at risk for diabetes mellitus","volume":"121","author":"Salpeter","year":"2008","journal-title":"Am J Med"},{"key":"R45-20250512","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-20250512","first-page":"Cd008565","article-title":"Statins for women with polycystic ovary syndrome not actively trying to conceive","volume":"10","author":"Raval","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R47-20250512","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/jc.2017-02667","article-title":"Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes","volume":"103","author":"Berni","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-20250512","doi-asserted-by":"crossref","first-page":"279.e271","DOI":"10.1016\/j.ajog.2018.06.017","article-title":"Association among depression, symptom experience, and quality of life in polycystic ovary syndrome","volume":"219","author":"Greenwood","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R49-20250512","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:18:10Z","timestamp":1747063090000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000597","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,18]]}}}